Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07139808

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

Led by Henan University of Science and Technology · Updated on 2026-04-07

12

Participants Needed

2

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is to evaluate the accuracy and safety of a novel real-time continuous glucose and ketone monitoring system among adult patients with type 1 diabetes mellitus (T1DM) with respect to Yellow Spring Instrument (YSI) and Randox reference venous plasma sample measurements.

CONDITIONS

Official Title

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 65 18 years
  • Diagnosed with type 1 diabetes mellitus and using continuous subcutaneous insulin infusion (CSII)
  • Able to have venous blood sampling access in the forearm
  • Capable of reading instructions independently and following clinical trial requirements
  • Willing to sign the Informed Consent Form (ICF)
Not Eligible

You will not qualify if you...

  • Severe hypoglycemia within the past 6 months
  • Diabetic ketoacidosis (DKA) diagnosed in the past 3 months
  • Heart failure or hemiplegic effects from previous cerebrovascular disease
  • Severe skin conditions at the sensor wear site
  • Extensive systemic skin disorders
  • Problems with wound healing, bleeding disorders, or use of anticoagulant medications
  • Anemia or abnormal hematocrit levels
  • Blood donation within the past 6 months
  • Pregnancy, breastfeeding, or plans for pregnancy within 30 days
  • Current or recent participation (within 1 month) in other clinical trials
  • Planned MRI or CT scans during sensor wear
  • Allergy to medical adhesives or alcohol
  • Conditions affecting understanding of informed consent or study procedures
  • Any other conditions that the investigator considers exclusionary

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China, 050000

Actively Recruiting

2

Henan University of Science and Technology

Luoyang, Henan, China, 471003

Actively Recruiting

Loading map...

Research Team

P

Peng Liu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here